Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response.
Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response
Each component has a specific meaning:
Note: Interpret the ph oxalate burden result against the thresholds and context described above.
Enter the 24-hour urinary oxalate, plasma oxalate, GFR, estimates crystallization risk, lumasiran/oxalate lowering therapy response for the scenario you are assessing. Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response. Use the ph oxalate burden result to inform your calculation.